Concord Biotech Limited (CONCORDBIO.NS)

INR 2147.65

(-1.18%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020
Total Assets 17 Billion 15.13 Billion 13.12 Billion 11.82 Billion 9.4 Billion
Total Current Assets 8.96 Billion 7.27 Billion 6.32 Billion 6.07 Billion 456.2 Million
Cash And Short Term Investments 3.1 Billion 1.71 Billion 1.61 Billion 2.01 Billion 456.2 Million
Cash and Cash Equivalents 151.42 Million 34.99 Million 6.67 Million 51.44 Million 456.2 Million
Short Term Investments 2.95 Billion 1.68 Billion 1.61 Billion 1.96 Billion 1.98 Billion
Net Receivables 3.49 Billion 3.42 Billion 2.32 Billion 1.77 Billion 1.83 Billion
Inventory 2.07 Billion 2.12 Billion 1.95 Billion 1.53 Billion 1.11 Billion
Other Current Assets 284.93 Million 7.12 Million 1.17 Billion 2.15 Billion 2.41 Billion
Total Non-Current Assets 8.04 Billion 7.86 Billion 6.8 Billion 5.75 Billion 920 Thousand
Net PPE 7.86 Billion 7.65 Billion 6.43 Billion 5.57 Billion 3.8 Billion
Good Will And Intangible Assets 3.19 Million 2 Million 35.79 Million 64.18 Million 930 Thousand
Good Will - - - - -
Intangible Assets 3.19 Million 2 Million 35.79 Million 64.18 Million 930 Thousand
Long-Term Investments -2.88 Billion -1.68 Billion -1.6 Billion -1.95 Billion 8.15 Million
Tax Assets 2.97 Billion - - - -3.81 Billion
Other Non Current Assets 79.79 Million 1.88 Billion 1.93 Billion 2.06 Billion -930 Thousand
Other Assets - - - - 8.94 Billion
Total Liabilities 1.74 Billion 2.23 Billion 2.09 Billion 1.83 Billion 1.7 Billion
Total Current Liabilities 1.42 Billion 1.91 Billion 1.55 Billion 1.05 Billion 1.15 Billion
Account Payables 944.35 Million 938 Million 831.06 Million 463.97 Million 712.33 Million
Tax Payables 54.93 Million 89.99 Million - - -
Short Term Debt 78.5 Million 251.47 Million 309.34 Million 314 Million 125 Million
Deferred Revenue 336.02 Million - - - -
Other Current Liabilities 62.67 Million 728.99 Million 411.28 Million 279.42 Million 313.62 Million
Total Non Current Liabilities 319.07 Million 321.37 Million 544.04 Million 774.34 Million 551.86 Million
Long-Term Debt 18.87 Million 64 Million 315.59 Million 578.83 Million 384.63 Million
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 19.56 Million 22.97 Million 18.74 Million 20.98 Million 167.23 Million
Other Liabilities - - - - -
Total Equity 15.26 Billion 12.9 Billion 11.03 Billion 9.99 Billion 6.48 Billion
Stock Holders Equity 15.26 Billion 12.9 Billion 11.03 Billion 9.99 Billion 6.48 Billion
Common Stock 104.61 Million 104.62 Million 95.11 Million 95.11 Million 95.11 Million
Retained Earnings 14.04 Billion 11.68 Billion 9.81 Billion 8.77 Billion 6.48 Billion
Accumulated other comprehensive income 292.17 Million - - - -
Common Stock Equity 15.26 Billion 12.9 Billion 11.03 Billion 9.99 Billion 6.48 Billion
Capital Lease Obligation 35.07 Million 3.11 Million 19.07 Million 29.34 Million 40.26 Million
Total Investments 70.28 Million 1.25 Million 2.56 Million 3.66 Million 1.98 Billion
Total Debt 97.37 Million 315.47 Million 624.93 Million 892.83 Million 509.63 Million
Net Debt -54.04 Million 280.48 Million 618.26 Million 841.39 Million 53.43 Million

Balance Sheet Charts